Ozempic Linked to 30% Lower Breast Cancer Risk: What the 2026 Study Found
Ozempic Linked to 30% Lower Breast Cancer Risk A groundbreaking study published June 2, 2026, in JCO Oncology Practice — and presented to a standing-room audience at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago — has revealed that women taking GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are approximately […]
Ozempic Linked to 30% Lower Breast Cancer Risk: What the 2026 Study Found Read More »







